Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative chemotherapy and panitumumab trial in high-risk operable colon cancer
2007-001987-55Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Aug 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of panitumumab, fluorouracil, oxaliplatin, capecitabine and folinic acid in colon cancer (3 arms), sponsored by University of Birmingham. Primary endpoint: Freedom from recurrence or persistent disease at 2 years. Status: unknown.
02
Drugs
panitumumabfluorouraciloxaliplatincapecitabinefolinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2007-001987-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001987-55.